MedTrace Logo

Descemet Membrane Endothelial Keratoplasty (DMEK)

NCT00521898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2023-01-12

No results posted yet for this study

Summary

To evaluate isolated Descemet membrane transplantation as a refinement of previous advanced techniques for corneal transplantation, like Descemet Stripping Endothelial Keratoplasty (DSEK)

Conditions

  • Corneal Dystrophies, Hereditary

Interventions

PROCEDURE

Descemet Membrane Endothelial Keratoplasty (DMEK)

Sponsors & Collaborators

  • Amnitrans Eyebank Rotterdam

    collaborator OTHER

  • Netherlands Institute for Innovative Ocular Surgery

    lead OTHER

Principal Investigators

  • Gerrit R Melles, MD, PhD · Netherlands Institute for Innovative Ocular Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00521898 on ClinicalTrials.gov